Learning Objectives:
1. Discuss the spectrum of childhood-onset hyperkinetic disorders and continue into adulthood including paroxysmal (ATP1A3, ADCY5, KCNMA1) and dyskinesia-epilepsy spectrum disorders (GNAO1)
2. Describe the spectrum of childhood-onset treatable hyperkinetic disorders and emerging precision therapies
3. Approach diseases most amenable to deep brain stimulation and decide the ideal timing for DBS